The Physalis Child : Identification of Cognitive and Emotional Factors
NCT ID: NCT02567500
Last Updated: 2018-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2015-07-07
2017-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral and Cognitive Therapies for Auditory Hallucination Management
NCT03348787
Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia
NCT06599372
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
NCT04481217
Prevalence of Dissociative Disorders in Children
NCT01512641
Neurostimulation-enhanced Behavioral Remediation of Social Cognition in Schizophrenia
NCT03213600
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with auditory hallucination
Patients with auditory hallucination:
Evaluation at time 0 and 6 month after of:
* The social cognitive marker (NeuroPsychologic assessment (NEPSY) II) : theory of mind and affect recognition
* The emotional marker:
* Differential Emotion Scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with Diagnostic and Statistical Manual of Mental Disorders (DSM) -IV criteria:
* Mini International Neuropsychiatric Interview (MINI) -Kids
* "Psychosis" section of Kiddie-SADS
Patients with auditory hallucination
Patients with auditory hallucination (20 for each arm):
Evaluation at time 0 and 6 month after of:
* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:
* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:
* MINI-Kids
* "Psychosis" section of Kiddie-SADS
Patients without auditory hallucination
Patients without auditory hallucination:
Evaluation at time 0 and 6 month after of:
* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:
* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with Diagnostic and Statistical Manual of Mental Disorders (DSM) -IV criteria:
* Mini International Neuropsychiatric Interview (MINI) -Kids
* "Psychosis" section of Kiddie-SADS (Schedule for Affective Disorders and Schizophrenia )
Patients without auditory hallucination
Patients without auditory hallucination (20 for each arm):
Evaluation at time 0 and 6 month after of:
* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:
* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:
* MINI-Kids
* "Psychosis" section of Kiddie-SADS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients with auditory hallucination
Patients with auditory hallucination (20 for each arm):
Evaluation at time 0 and 6 month after of:
* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:
* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:
* MINI-Kids
* "Psychosis" section of Kiddie-SADS
Patients without auditory hallucination
Patients without auditory hallucination (20 for each arm):
Evaluation at time 0 and 6 month after of:
* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:
* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:
* MINI-Kids
* "Psychosis" section of Kiddie-SADS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Boy or girl
* French
* Over six years old and under eighteen years old
* DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (Intelligence Quotient (IQ)\>70),
* Parental and child consent, affiliated to social security.
* Twenty participants included without auditory hallucination:
* Boy or girl
* French,
* Over six years old and under eighteen years old
* DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (IQ\>70)
* Parental and child consent, affiliated to social security.
Exclusion Criteria
* neurologic, genetic or neurosensory disorders
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Lenval
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valérie BONNARD-COUTON, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation Lenval
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Lenval
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dumas LE, Bonnard-Couton V, Golse B, Askenazy F. [Identifying cognitive and emotional markers in relation to auditory-verbal hallucinations in pediatric population: Physalis study]. Encephale. 2022 Oct;48(5):546-554. doi: 10.1016/j.encep.2021.06.010. Epub 2021 Oct 5. French.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-HPNCL-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.